메뉴 건너뛰기




Volumn 37, Issue 2, 2012, Pages 217-220

Pharmacokinetics: Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase

Author keywords

Mycophenolic acid; Mycophenolic acid phenolic glucuronide; Pharmacokinetics; Prednisolone dose reduction; Systemic lupus erythematosus; Therapeutic efficacy

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOUBLE STRANDED DNA ANTIBODY; GLUCURONIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNINE; PREDNISOLONE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID BETA D GLUCURONIDE;

EID: 84857999325     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01269.x     Document Type: Article
Times cited : (11)

References (31)
  • 1
    • 3042743984 scopus 로고    scopus 로고
    • Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation
    • DOI 10.1111/j.1600-6143.2004.00455.x
    • Kiberd BA, Lawen J, Fraser AD, Keough-Ryan T, Belitsky P Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. American Journal of Transplantation, 2004;4:1079-1083. (Pubitemid 38868597)
    • (2004) American Journal of Transplantation , vol.4 , Issue.7 , pp. 1079-1083
    • Kiberd, B.A.1    Lawen, J.2    Fraser, A.D.3    Keough-Ryan, T.4    Belitsky, P.5
  • 3
    • 0034869311 scopus 로고    scopus 로고
    • Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus
    • Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. The Journal of Rheumatology, 2001;28:2103-2108. (Pubitemid 32803791)
    • (2001) Journal of Rheumatology , vol.28 , Issue.9 , pp. 2103-2108
    • Buratti, S.1    Szer, I.S.2    Spencer, C.H.3    Bartosh, S.4    Reiff, A.5
  • 4
    • 0036051895 scopus 로고    scopus 로고
    • Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents
    • Karim MY, Alba P, Cuadrado MJ et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford), 2002;41:876-882.
    • (2002) Rheumatology (Oxford) , vol.41 , pp. 876-882
    • Karim, M.Y.1    Alba, P.2    Cuadrado, M.J.3
  • 8
    • 34948895412 scopus 로고    scopus 로고
    • Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: Mycophenolate mofetil or intravenous cyclophosphamide
    • DOI 10.1177/0961203307081340
    • Wang J, Hu W, Xie H et al. Induction therapies for class IV lupus nephritis with noninflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide. Lupus, 2007;16:707-712. (Pubitemid 47517865)
    • (2007) Lupus , vol.16 , Issue.9 , pp. 707-712
    • Wang, J.1    Hu, W.2    Xie, H.3    Zhang, H.4    Chen, H.5    Zeng, C.6    Liu, Z.7    Li, L.8
  • 9
    • 0031748776 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of mycophenolate mofetil
    • DOI 10.2165/00003088-199834060-00002
    • Bullingham RE, Nicholls AJ, Kamm BR Clinical pharmacokinetics of mycophenolate mofetil. Clinical Pharmacokinetics, 1998;34:429-455. (Pubitemid 28273453)
    • (1998) Clinical Pharmacokinetics , vol.34 , Issue.6 , pp. 429-455
    • Bullingham, R.E.S.1    Nicholls, A.J.2    Kamm, B.R.3
  • 11
    • 0034961129 scopus 로고    scopus 로고
    • Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation
    • Mourad M, Malaise J, Chaib Eddour D et al. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clinical Chemistry, 2001;47:1241-1248. (Pubitemid 32579112)
    • (2001) Clinical Chemistry , vol.47 , Issue.7 , pp. 1241-1248
    • Mourad, M.1    Malaise, J.2    Eddour, D.C.3    De Meyer, M.4    Konig, J.5    Schepers, R.6    Squifflet, J.P.7    Wallemacq, P.8
  • 13
    • 54149103127 scopus 로고    scopus 로고
    • Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
    • Neumann I, Fuhrmann H, Fang IF, Jaeger A, Bayer P, Kovarik J Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil. Nephrology Dialysis Transplantation, 2008;23:3514-3520.
    • (2008) Nephrology Dialysis Transplantation , vol.23 , pp. 3514-3520
    • Neumann, I.1    Fuhrmann, H.2    Fang, I.F.3    Jaeger, A.4    Bayer, P.5    Kovarik, J.6
  • 14
    • 42649099997 scopus 로고    scopus 로고
    • Pharmacokinetics of enteric-coated mycophenolate sodium: Comparative study in patients with autoimmune disease and renal allograft
    • DOI 10.1517/14656566.9.6.879
    • Neumann I, Fuhrmann H, Kanzler M et al. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft. Expert Opinion on Pharmacotherapy, 2008;9:879-886. (Pubitemid 351593736)
    • (2008) Expert Opinion on Pharmacotherapy , vol.9 , Issue.6 , pp. 879-886
    • Neumann, I.1    Fuhrmann, H.2    Kanzler, M.3    Fang, I.-F.4    Jaeger, A.5    Graf, H.6    Bayer, P.7    Kovarik, J.8
  • 15
    • 57749086299 scopus 로고    scopus 로고
    • Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation
    • Mino Y, Naito T, Matsushita T et al. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Therapeutic Drug Monitoring, 2008;30:656-661.
    • (2008) Therapeutic Drug Monitoring , vol.30 , pp. 656-661
    • Mino, Y.1    Naito, T.2    Matsushita, T.3
  • 16
    • 40549127818 scopus 로고    scopus 로고
    • Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies
    • Zahr N, Amoura Z, Debord J et al. Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies. Clinical Pharmacokinetics, 2008;47:277-284. (Pubitemid 351367437)
    • (2008) Clinical Pharmacokinetics , vol.47 , Issue.4 , pp. 277-284
    • Zahr, N.1    Amoura, Z.2    Debord, J.3    Hulot, J.-S.4    Saint-Marcoux, F.5    Marquet, P.6    Piette, J.C.7    Lechat, P.8
  • 17
    • 59949088265 scopus 로고    scopus 로고
    • Pharmacokinetics of mycophenolic acid in patients with lupus nephritis
    • Joy MS, Hilliard T, Hu Y et al. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy, 2009;29:7-16.
    • (2009) Pharmacotherapy , vol.29 , pp. 7-16
    • Joy, M.S.1    Hilliard, T.2    Hu, Y.3
  • 18
    • 34548051575 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis
    • Czock D, Rasche FM, Carius A et al. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis. The Journal of Clinical Pharmacology, 2007;47:850-859.
    • (2007) The Journal of Clinical Pharmacology , vol.47 , pp. 850-859
    • Czock, D.1    Rasche, F.M.2    Carius, A.3
  • 19
    • 0029899127 scopus 로고    scopus 로고
    • Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid
    • DOI 10.1016/S0092-8674(00)81275-1
    • Sintchak MD, Fleming MA, Futer O et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell, 1996;85:921-930. (Pubitemid 26192142)
    • (1996) Cell , vol.85 , Issue.6 , pp. 921-930
    • Sintchak, M.D.1    Fleming, M.A.2    Futer, O.3    Raybuck, S.A.4    Chambers, S.P.5    Caron, P.R.6    Murcko, M.A.7    Wilson, K.P.8
  • 20
    • 57749117648 scopus 로고    scopus 로고
    • Pharmacodynamics of mycophenolic acid in CD4+ cells: A single-dose study of IMPDH and purine nucleotide responses in healthy individuals
    • Vethe NT, Bremer S, Rootwelt H, Bergan S Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals. Therapeutic Drug Monitoring, 2008;30:647-655.
    • (2008) Therapeutic Drug Monitoring , vol.30 , pp. 647-655
    • Vethe, N.T.1    Bremer, S.2    Rootwelt, H.3    Bergan, S.4
  • 22
    • 65649140169 scopus 로고    scopus 로고
    • Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
    • Appel GB, Contreras G, Dooley MA et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. Journal of the American Society of Nephrology, 2009;20:1103-1112.
    • (2009) Journal of the American Society of Nephrology , vol.20 , pp. 1103-1112
    • Appel, G.B.1    Contreras, G.2    Dooley, M.A.3
  • 23
    • 37749033876 scopus 로고    scopus 로고
    • Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography
    • Mino Y, Naito T, Matsushita T, Kagawa Y, Kawakami J Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 2008;46:603-608.
    • (2008) Journal of Pharmaceutical and Biomedical Analysis , vol.46 , pp. 603-608
    • Mino, Y.1    Naito, T.2    Matsushita, T.3    Kagawa, Y.4    Kawakami, J.5
  • 24
    • 33746442024 scopus 로고    scopus 로고
    • Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus
    • Su DL, Wang HJ, Ji XH et al. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Acta Pharmacologica Sinica, 2006;27:1051-1057.
    • (2006) Acta Pharmacologica Sinica , vol.27 , pp. 1051-1057
    • Su, D.L.1    Wang, H.J.2    Ji, X.H.3
  • 25
    • 33746383697 scopus 로고    scopus 로고
    • The abnormal expression of IL-10, IFN-c, IP-10 and IL-12 in patients with systemic lupus erythematosus and the effects of cyclosporine A and cyclophosphamide on it
    • Jiang YZ, Ji XH, Ji YF, Su DL The abnormal expression of IL-10, IFN-c, IP-10 and IL-12 in patients with systemic lupus erythematosus and the effects of cyclosporine A and cyclophosphamide on it. Acta Universitatis Medicinalis Nanjing, 2005;25:633-636.
    • (2005) Acta Universitatis Medicinalis Nanjing , vol.25 , pp. 633-636
    • Jiang, Y.Z.1    Ji, X.H.2    Ji, Y.F.3    Su, D.L.4
  • 26
    • 0035043299 scopus 로고    scopus 로고
    • Treatment of lupus with corticosteroids
    • DOI 10.1191/096120301675075008
    • Chatham WW, Kimberly RP Treatment of lupus with corticosteroids. Lupus, 2001;10:140-147. (Pubitemid 32410067)
    • (2001) Lupus , vol.10 , Issue.3 , pp. 140-147
    • Chatham, W.W.1    Kimberly, R.P.2
  • 27
    • 0029058395 scopus 로고
    • Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics
    • Nowak I, Shaw LM Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clinical Chemistry, 1995;41:1011-1017.
    • (1995) Clinical Chemistry , vol.41 , pp. 1011-1017
    • Nowak, I.1    Shaw, L.M.2
  • 30
    • 33748184749 scopus 로고    scopus 로고
    • Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: Comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry
    • DOI 10.1097/01.ftd.0000197092.84935.ef, PII 0000769120060400000022
    • Prémaud A, Rousseau A, Picard N, Marquet P Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Therapeutic Drug Monitoring, 2006;28:274-277. (Pubitemid 44314962)
    • (2006) Therapeutic Drug Monitoring , vol.28 , Issue.2 , pp. 274-277
    • Premaud, A.1    Rousseau, A.2    Picard, N.3    Marquet, P.4
  • 31
    • 63649157074 scopus 로고    scopus 로고
    • Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients
    • Mino Y, Naito T, Otsuka A et al. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients. Clinical Biochemistry, 2009;42:595-601.
    • (2009) Clinical Biochemistry , vol.42 , pp. 595-601
    • Mino, Y.1    Naito, T.2    Otsuka, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.